| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| .821 shares Liberty All Star Equity | 2021-12 | Purchased | 2022-06 | 6 | 7 | -1 | ||||
| 20 shares Organon & Company | Purchased | 2022-04 | 589 | 298 | 291 | |||||
| .960 shares Warner Bros. Discovery | 2020-01 | Purchased | 2022-04 | 22 | 36 | -14 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| Essentials Utils. | 2,318 | 5,904 |
| FNB Corporate Dep. Shrs. | 8,578 | 8,146 |
| Franklin Income Fund | 25,000 | 23,554 |
| AT & T | 15,048 | 10,480 |
| Merck & Co. | 5,976 | 18,281 |
| Oppenheimer Steel Path MLP Income Fund | 22,802 | 16,623 |
| Royal Dutch Shell PLC | 16,185 | 15,722 |
| Bristol Myers Squibb Company | 4,879 | 7,700 |
| PPL Corporation | 18,641 | 13,565 |
| Liberty All Star Equity | 6,654 | 5,162 |
| Warner Bros. Discovery | 4,581 | 1,610 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Scholarships | 6,000 | 0 | 0 | 6,000 |
| Penalties-excise tax on inv. income | 8 | 0 | 0 | 0 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| Long term capital gain distributions | 544 | 544 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Foreign taxes | 43 | 43 | 43 | 0 |
| Excise tax on inv. income | 200 | 0 | 0 | 0 |